Tenet Healthcare Corporation [NYSE: THC] closed the trading session at $29.78 on 09/17/20. The day’s price range saw the stock hit a low of $28.06, while the highest price level was $29.97.
The stocks have a year to date performance of -21.69 percent and weekly performance of 2.94 percent. The stock has been moved at 115.95 percent over the last six months. The stock has performed 5.83 percent around the most recent 30 days and changed 39.22 percent over the most recent 3-months.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
If compared to the average trading volume of 1.65M shares, THC reached to a volume of 1439330 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Tenet Healthcare Corporation [THC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for THC shares is $30.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on THC stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
RBC Capital Mkts have made an estimate for Tenet Healthcare Corporation shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on March 11, 2020. The new note on the price target was released on February 26, 2020, representing the official price target for Tenet Healthcare Corporation stock. On November 06, 2019, analysts increased their price target for THC shares from 25 to 36.
The Average True Range (ATR) for Tenet Healthcare Corporation is set at 1.40, with the Price to Sales ratio for THC stock in the period of the last 12 months amounting to 0.18. Price to Free Cash Flow for THC in the course of the last twelve months was 1.16 with Quick ratio for the last quarter at 1.40.
THC stock trade performance evaluation
Tenet Healthcare Corporation [THC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.94. With this latest performance, THC shares gained by 5.83% in over the last four-week period, additionally plugging by 115.95% over the last 6 months – not to mention a rise of 19.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for THC stock in for the last two-week period is set at 59.63, with the RSI for the last a single of trading hit 58.94, and the three-weeks RSI is set at 58.46 for Tenet Healthcare Corporation [THC]. The present Moving Average for the last 50 days of trading for this stock 26.59, while it was recorded at 29.17 for the last single week of trading, and 25.91 for the last 200 days.
Tenet Healthcare Corporation [THC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Tenet Healthcare Corporation [THC] shares currently have an operating margin of +9.09 and a Gross Margin at +9.09. Tenet Healthcare Corporation’s Net Margin is presently recorded at -1.32.
Return on Total Capital for THC is now 9.68, given the latest momentum, and Return on Invested Capital for the company is -1.64. Additionally, THC Total Debt to Total Capital is recorded at 102.41, with Total Debt to Total Assets ending up at 67.53.
Reflecting on the efficiency of the workforce at the company, Tenet Healthcare Corporation [THC] managed to generate an average of -$2,139 per employee. Receivables Turnover for the company is 5.99 with a Total Asset Turnover recorded at a value of 0.81.Tenet Healthcare Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.40.
Earnings per share (EPS) analysis for Tenet Healthcare Corporation [THC] stock
With the latest financial reports released by the company, Tenet Healthcare Corporation posted 0.58/share EPS, while the average EPS was predicted by analysts to be reported at 0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 87.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for THC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Tenet Healthcare Corporation go to 11.76%.
Tenet Healthcare Corporation [THC]: Insider Ownership positions
There are presently around $3,071 million, or 98.70% of THC stock, in the hands of institutional investors. The top three institutional holders of THC stocks are: GLENVIEW CAPITAL MANAGEMENT, LLC with ownership of 19,761,353, which is approximately 0.13% of the company’s market cap and around 1.20% of the total institutional ownership; BLACKROCK INC., holding 12,394,095 shares of the stock with an approximate value of $369.1 million in THC stocks shares; and VANGUARD GROUP INC, currently with $358.69 million in THC stock with ownership of nearly -5.056% of the company’s market capitalization.
Positions in Tenet Healthcare Corporation stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 128 institutional holders increased their position in Tenet Healthcare Corporation [NYSE:THC] by around 10,033,752 shares. Additionally, 124 investors decreased positions by around 12,577,339 shares, while 47 investors held positions by with 80,508,765 shares. The mentioned changes placed institutional holdings at 103,119,856 shares, according to the latest SEC report filing. THC stock had 38 new institutional investments in for a total of 3,926,084 shares, while 53 institutional investors sold positions of 6,482,307 shares during the same period.